Filing Details
- Accession Number:
- 0001209191-22-041962
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-12 18:24:07
- Reporting Period:
- 2022-05-27
- Accepted Time:
- 2022-07-12 18:24:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1652724 | Lucira Health Inc. | LHDX | In Vitro & In Vivo Diagnostic Substances (2835) | 272491037 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1870312 | Walter Kevin Collins | C/O Lucira Health, Inc. 1412 62Nd Street Emeryville CA 94608 | Chief Revenue Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-05-27 | 37,109 | $2.00 | 364,968 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 18, 2021 for 396,975 shares.
- Includes 5,102 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on February 20, 2022.
Billionaire Hedge Funds
